课题基金 / 基金详情

BLRD Research Career Scientist Award Application

BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
批准号:
10594020
负责人:
Katrin F Chua
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2027-03-31
关键词:
AddressAgeAgingAreaAutomobile DrivingAwardBindingBiochemicalBiochemistryBiological ProcessBiologyBiology of AgingCancer BiologyCardiovascular DiseasesCell AgingCell physiologyCellsChromatinChronic DiseaseCollaborationsDNA DamageDNA SequenceDNA Sequence AlterationDefectDiabetes MellitusDirect CostsDiseaseEnzymesEpigenetic ProcessFunctional disorderFundingFutureGene Expression RegulationGene FamilyGenesGenetic TranscriptionGenomic InstabilityGenomic approachGenomicsGoalsGrantHealthHealthcareHeart DiseasesHeterochromatinHistone DeacetylaseHistone DeacetylationHomeostasisHumanImpairmentInflammationInflammatoryJournalsLeadLinkLiver diseasesLongevityLysineMalignant NeoplasmsMediatingMetabolicMetabolic DiseasesMetabolic stressMetabolismMethylationMolecularMolecular BiologyMorbidity - disease rateMusculoskeletalNatureNeoplasm MetastasisNerve DegenerationNuclearObesityOncogenicOrganismOrphanOxidative StressPaperPathogenicityPathologicPathologyPathway interactionsPhysiologicalPhysiologyPopulationProcessProteinsProteomicsPublishingReaderRegulationResearchResearch ActivityResearch PersonnelResistanceRisk FactorsRoleScientistSignal PathwaySignal TransductionSirtuinsSquamous Cell Lung CarcinomaStressSystemTherapeuticTissuesTranscriptTranslatingUnited States National Institutes of HealthUniversitiesUntranslated RNAVeteransWorkage relatedagedcareerepigenomicsgene networkhistone methyltransferaseimmunosenescenceimprovedin vivoinsightinterestmembermilitary veteranmouse modelmuscle regenerationneoplasticnon-alcoholic fatty liver diseasenovelnovel therapeutic interventionpatient populationpreventprofessorprogramssenescencestem cell biologystructural biologytargeted treatmenttelomeretumor growth

项目摘要

项目成果

Katrin F Chua的其他基金

相似基金

相关文献

中文摘要
翻译
衰老是许多慢性疾病的最大风险因素,包括癌症、神经变性、糖尿病、 和心脏病目前,大约一半的退伍军人事务部人口年龄在65岁以上,在未来十年, 预计这些退伍军人中有300多万人将超过75岁。因此,研究调节衰老的基因 衰老相关的病理学对于生物医学的进步至关重要, 健康这项研究计划调查了两个这样的基因,SIRT6和SIRT7,它们是“主基因”。 衰老组织中许多变化的“调节因子”,如DNA损伤,代谢和氧化应激, 细胞衰老和炎症。我们的项目研究这些基因活性的降低如何可能 有助于心血管和肝脏疾病,糖尿病,肥胖和许多癌症的病理,以及如何 激活这些基因可以防止这些疾病。通过确定可以针对 对于治疗,这项研究可以直接影响退伍军人的健康。 .
英文摘要
Aging is the greatest risk factor for many chronic diseases including cancer, neurodegeneration, diabetes, and heart disease. Currently, roughly half of the VA population is aged 65+ years, and in the next ten years, more than 3 million of these veterans are expected to be over 75. Thus, studying genes that regulate aging and aging-associated pathologies is critically important for biomedical advancements to benefit veterans’ health. This research program investigates two such genes, SIRT6 and SIRT7, which are “master regulators” of many changes in aging tissues, such as DNA damage, metabolic and oxidative stress, cellular senescence, and inflammation. Our projects study how decreased activity of these genes may contribute to pathologies in cardiovascular and liver disease, diabetes, obesity, and many cancers, and how activating these genes could protect against these pathologies. By identifying pathways that can be targeted for therapy, this research can directly impact the health of the Veteran population. .
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Medical Scientist Training Program
  • 批准号:
    10410260
  • 项目类别:
  • 资助金额:
    $182.52万
  • 财政年份:
    2022
  • 负责人:
    Katrin F Chua
  • 依托单位:
Medical Scientist Training Program
  • 批准号:
    10621959
  • 项目类别:
  • 资助金额:
    $197.38万
  • 财政年份:
    2022
  • 负责人:
    Katrin F Chua
  • 依托单位:
Histone Deacetylation Signaling in Aging and Cancer Pathways
Histone Deacetylation Signaling in Aging and Cancer Pathways
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: